Disease severity and symptom improvement were observed among patients with palmoplantar pustulosis who were treated with apremilast for 52 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback